NCT07608510

Brief Summary

This is a companion real-world external validation study of two pre-registered parent randomized controlled trials (RCTs, protocol IDs: FujianUTCM-1 and FujianUTCM-2). We aim to validate the generalizability and clinical applicability of a pre-developed machine learning prediction model (for Tai Chi intervention cognitive benefit population characteristics and individualized dose prescription) in a real-world community-dwelling population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started May 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
May 2026Mar 2027

First Submitted

Initial submission to the registry

March 27, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

May 27, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

March 27, 2026

Last Update Submit

May 24, 2026

Conditions

Keywords

mild cognitive impairmenttaijimachine learningExternal ValidationReal-World Study

Outcome Measures

Primary Outcomes (1)

  • Montreal Cognitive Assessment

    Global cognition

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

Secondary Outcomes (7)

  • Wechsler Memory Scale

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Digital Symbol test

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Trial Making Test part B

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Stroop color word test

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Boston naming test

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • +2 more secondary outcomes

Other Outcomes (6)

  • Blood glucose metabolism index

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Blood lipid metabolism index

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • Resting-State Functional Magnetic Resonance Imaging: Default Mode Network Functional Connectivity Structural Magnetic Resonance Imaging: Hippocampal Volume

    Single cross-sectional assessment at the time of study enrollment (baseline visit)

  • +3 more other outcomes

Study Arms (1)

Cross-Sectional External Validation Cohort

This is the only study population for this cross-sectional observational real-world external validation study. The cohort consists of community-dwelling older adults aged 60 years and above, who are diagnosed with Mild Cognitive Impairment (MCI) and have long-term regular Tai Chi practice. Participants will be recruited from communities in Fuzhou, China, with a planned sample size of 150 participants. This study will conduct a single time-point cross-sectional survey on this population, with no prospective follow-up. The sole objective is to externally validate the generalizability and clinical applicability of a pre-developed machine learning prediction model (for identifying MCI populations who gain significant cognitive benefits from Tai Chi intervention and formulating individualized Tai Chi dose prescriptions) in a real-world community setting.

Behavioral: 24-form Simplified Tai Chi (Observational Behavioral Exposure)

Interventions

This is the core observational exposure factor of this cross-sectional real-world external validation study, NOT an intervention actively assigned, implemented or manipulated by the investigator. This study only observes and records the existing long-term regular Tai Chi practice behavior (including dose, frequency and duration) of enrolled older adults with Mild Cognitive Impairment (MCI) during a single time-point cross-sectional survey, for the sole purpose of externally validating the generalizability of a pre-developed machine learning prediction model for Tai Chi cognitive benefit population identification and individualized dose prescription. No active behavioral intervention will be administered to any participant in this study.

Cross-Sectional External Validation Cohort

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This cross-sectional real-world external validation study will enroll 150 community-dwelling older adults aged 60 years and above, who are diagnosed with Mild Cognitive Impairment (MCI) and have regular practice of standardized 24-form simplified Tai Chi for at least 6 months (consistent with the form used in the parent RCTs). Eligible participants will be recruited from communities in Fuzhou, China, to validate the generalizability and clinical applicability of a pre-developed machine learning prediction model for Tai Chi cognitive benefit population identification.

You may qualify if:

  • \. Presence of mild cognitive impairment, not demented; 2. Age ≥ 60 years old; 3.Regular practice of standardized 24-form simplified Tai Chi for at least 6 months (consistent with the form used in the parent randomized controlled trials \[RCTs\]) ; 4.Informed consent and voluntary participation.

You may not qualify if:

  • Geriatric Depression Scale score ≥ 9 points
  • Cognitive impairment caused by other reasons, taking drugs, poisoning, etc;
  • Suffer from severe musculoskeletal system diseases and other contraindications to exercise and are not suitable for Tai Chi training, such as those who suffer from stroke, Parkinson's disease, and have a history of lower limb arthritis, hip and knee joint replacement, etc;
  • Patients with severe heart, liver, kidney failure, malignant tumors, and other major diseases;
  • Individuals with visual/auditory impairments, writing/reading impairments, illiteracy, etc. that affect training and evaluation;
  • Individuals with uncontrolled hypertension (systolic blood pressure greater than 160mmHg or diastolic blood pressure greater than 100mmHg after medication);
  • Participating in other experiments that influence this study. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

APOE Genotype

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 27, 2026

First Posted

May 27, 2026

Study Start

May 15, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

May 27, 2026

Record last verified: 2026-04